CompletedPhase 4NCT00443430
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
Studying Juvenile idiopathic arthritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Seattle Children's Hospital
- Principal Investigator
- Carol A. Wallace, MDChildrens Hospital and Regional Medical Center
- Intervention
- methotrexate(drug)
- Enrollment
- 85 enrolled
- Eligibility
- 2-17 years · All sexes
- Timeline
- 2007 – 2010
Study locations (15)
- Stanford University Medical Center, Palo Alto, California, United States
- Rady Children's Hospital, San Diego, California, United States
- University of California San Francisco Medical Center, San Francisco, California, United States
- Children's Hospital of Boston, Boston, Massachusetts, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- Schneider Children's Hospital, New Hyde Park, New York, United States
- Children's Hospital at Montefiore, The Bronx, New York, United States
- Duke University, Durham, North Carolina, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Cleveland Clinic Foundation, Cleveland, Ohio, United States
- Children's Hospital of Columbus, Columbus, Ohio, United States
- Oklahoma University Health Science Center, Oklahoma City, Oklahoma, United States
- Texas Scottish Rite Hospital, Dallas, Texas, United States
- University of Utah, Salt Lake City, Utah, United States
- Seattle Children's Hospital and Regional Medical Center, Seattle, Washington, United States
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Amgen
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00443430 on ClinicalTrials.govOther trials for Juvenile idiopathic arthritis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE3NCT07386587Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic ArthritisUniversity of Child Health Sciences and Children's Hospital, Lahore
- RECRUITINGPHASE3NCT06654882Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisDuke University
- RECRUITINGNCT07243782Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in KoreaNovartis Pharmaceuticals
- RECRUITINGNANCT07217782Pain in Juvenile ArthritisWashington University School of Medicine
- RECRUITINGNCT07185750Investigation of Catastrophizing of Pain Reported by Parents in JIA PatientsHacettepe University
- RECRUITINGNANCT07234747Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic ArthritisIstanbul University - Cerrahpasa
- RECRUITINGNCT06806774Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic ArthritisHacettepe University
- RECRUITINGNANCT06474546Feasibility of a Diet Intervention for Juvenile ArthritisThe Hospital for Sick Children